AbCellera Biologics Inc.ABCLNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-26.3%
5Y CAGR-23.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-26.3%/yr
vs +146.6%/yr prior
5Y CAGR
-23.6%/yr
Consistent
Acceleration
-172.9pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $155.01M | -0.8% |
| 2024 | $156.32M | +17.3% |
| 2023 | $133.32M | -65.5% |
| 2022 | $386.54M | -18.8% |
| 2021 | $476.14M | -19.9% |
| 2020 | $594.12M | +7766.0% |
| 2019 | $7.55M | -27.7% |
| 2018 | $10.44M | - |